Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma

Carcinogenesis

Volumn 35, Issue 7, 2014, Pages

  Schröck, Andreas ^a   Bode, Maike ^a   Göke, Friederike Johanna Maria ^a   Bareiss, Petra Marion ^b   Schairer, Rebekka ^b   Wang, Hui ^b   Franzen, Alina ^a   Kirsten, Robert ^a   van Bremen, Tobias ^a   Queisser, Angela ^a   Kristiansen, Glen ^a   Heasley, Lynn ^c   Bootz, Friedrich ^a   Lengerke, Claudia ^b   Perner, Sven ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Division of Cellular/Molecular Pharmacology   (Germany)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Amplification; Biomarker; HNSCC; HPV; SOX2

Indexed keywords

CISPLATIN; LENTIVIRUS VECTOR; PROTEIN BCL 2; STAUROSPORINE; TRANSCRIPTION FACTOR SOX2; MESSENGER RNA; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR MARKER;

ADULT; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RESISTANCE; CELL CYCLE ASSAY; CELL PROLIFERATION; CELLULAR PARAMETERS; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; GENE AMPLIFICATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WART VIRUS; CANCER GRADING; CANCER STAGING; COHORT ANALYSIS; ENZYME IMMUNOASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENETICS; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR RECURRENCE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOXB1 TRANSCRIPTION FACTORS; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84904009209     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu094     Document Type: Article

References (31)

1. Beroukhim R. , et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature, 463, 899-905.
2. Bullinger L. et al. (2008) An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML. Blood, 111, 4490-4495.
3. Weir B. et al. (2004) Somatic alterations in the human cancer genome. Cancer Cell, 6, 433-438.
4. Parkin D.M. et al. (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer, 41, 184-197.
5. Price K.A. et al. (2012) Current treatment options for metastatic head and neck cancer. Curr. Treat. Options Oncol., 13, 35-46.
6. Bass A.J. et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet., 41,1238-1242.
7. Park I.H. et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451,141-146.
8. Freier K. et al. (2010) Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer, 49, 9-16.
9. Perner S. et al. (2009) TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J. Pathol., 217, 65-72.
10. Wilbertz T. et al. (2011) SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod. Pathol., 24, 944-953.
11. Schröck A. et al. (2013) Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer. PLoS One, 8: e59201.
12. Göke F. et al. (2013) Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck. Mod. Pathol., 26,1298-1306.
13. Konantz M. et al. (2013) EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. Leukemia, 27, 56-65.
14. Anastasov N. et al. (2009) Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J. Hematop., 2, 9-19.
15. Bareiss P.M. et al. (2013) SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma. Cancer Res., 73, 5544-5555.
16. Lengerke C. et al. (2011) Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer, 11: 42.
17. Riedt T. et al. (2009) Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia. Blood, 113, 4049-4051.
18. O'Rorke M.A. et al. (2012) Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol., 48, 1191-1201.
19. Albertson D.G. et al. (2003) Chromosome aberrations in solid tumors. Nat. Genet., 34, 369-376.
20. Albertson D.G. Gene amplification in cancer. Trends Genet., 22, 447-455.
21. Pham D.L. et al. (2013) SOX2 expression and prognostic significance in ovarian carcinoma. Int. J. Gynecol. Pathol., 32, 358-367.
22. Hussenet T. et al. (2010) SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One, 5, e8960.
23. Ben-Porath I. et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet., 40, 499-507.
24. Jeter C.R. et al. (2009) Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells, 27, 993-1005.
25. Han X. et al. (2012) Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One, 7, e41335.
26. Michifuri Y. et al. (2012) High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol. Int., 62, 684-689.
27. Tang X.B. et al. (2013) SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma. Auris Nasus Larynx, 40, 481-486.
28. Sun C. et al. (2013) Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug. Med. Oncol., 30, 503.
29. Züllig L. et al. (2013) High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. Eur. J. Cancer, 49,1915-1922.
30. Chen Y. et al. (2008) The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J. Biol. Chem., 283, 17969-17978.
31. Lin F. et al. (2012) Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis. Cell Prolif., 45, 207-216.